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Vaccinologists strive to harness immunity atmucosal
sites of pathogen entry. We studied respiratory
delivery of an attenuated vaccine against Blasto-
myces dermatitidis. We created a T cell receptor
transgenic mouse responsive to vaccine yeast and
found thatmucosal vaccination led to poor T cell acti-
vation in the draining nodes and differentiation in
the lung. Mucosal vaccination subverted lung T cell
priming by inducing matrix metalloproteinase 2
(MMP2), which impaired the action of the chemokine
CCL7onegressofCCR2+Ly6Chi inflammatorymono-
cytes from the bone marrow and their recruitment to
the lung. Studies in Mmp2/ mice, or treatment
with MMP inhibitor or rCCL7, restored recruitment
of Ly6Chi monocytes to the lung and CD4+ T cell
priming. Mucosal vaccination against fungi and
perhaps other respiratory pathogens may require
manipulation of host MMPs in order to alter chemo-
kine signals needed to recruit Ly6Chi monocytes
and prime T cells at the respiratory mucosa.
INTRODUCTION
The rising rates of systemic fungal infections worldwide have
stimulated interest in developing vaccines (Cutler et al., 2007).
Although experimental vaccines are under study, none are
commercially available (Cutler et al., 2007). An understanding
of the mode of action of fungal vaccines will enhance their
application in human populations. Th1-cell responses mediated
by IL-12 and IFN-g are believed to foster protective immunity to
many pathogenic fungi (Wu¨thrich et al., 2012). During the earliest
stages of fungal infection, pattern recognition receptors on
myeloid lineage cells sense fungal pathogens and surfaces
(Brown, 2011). Myeloid cells, particularly dendritic cells (DCs),
bridge innate and adaptive immunity to pathogens. DCs have
thus become a target for vaccine development strategies
(Steinman, 2008).680 Immunity 36, 680–692, April 20, 2012 ª2012 Elsevier Inc.The lung airways of all species are lined with an intraepithelial
dendritic network of MHCIIhi CD11chi cells that are mostly
CD11b (Lambrecht and Hammad, 2009). The lamina propria
contains MHCIIhi CD11chi cells that express CD11b and elabo-
rate proinflammatory chemokines. CD11b+ and CD11b
subsets of DCs express high amounts of CD11c and are viewed
as conventional DCs, in contrast to a population of CD11cint
plasmacytoid DCs (pDCs). Lung alveoli contain CD11chi MHCIIhi
DCs, which are enriched in CD103+ subsets. Alveolar macro-
phages also express CD11c (not CD11b), confusing the analysis
of lung DCs unless autofluorescence is used for identifying
macrophages (Vermaelen and Pauwels, 2004). Under inflamma-
tory conditions, such asmicrobial challenge, CD11b+monocyte-
derived DCs that rapidly upregulate CD11c and retain Ly6C as
a remnant of monocytic descent are recruited (Shi and Pamer,
2011).
Monocyte-derived DCs are important for priming T cell
responses to microbes (Hohl et al., 2009; Serbina et al., 2008).
These DCs prime Th1 cell responses and IFN-g-producing Ag-
specific CD4+ transgenic (tg) T cells in pulmonary aspergillosis
(Hohl et al., 2009). In Aspergillus infection, CCR2+ Ly6Chi DCs
are required to prime T cells in the lung, yet not in the spleen.
We recently analyzed sequential stages during the induction of
vaccine immunity to fungi after subcutaneous (s.c.) injection
(Ersland et al., 2010). Monocyte-derived DCs initially take up
the most vaccine yeast and traffic them to the skin-draining
LNs. However, the direct priming of naive Ag-specific CD4
T cells in vivo is governed by LN-resident DCs and skin-derived
DCs. In fact, other skin DCs compensate for monocyte-derived
DCs in Ccr2/ mice lacking the cells.
Vaccinologists strive to harness protective immunity at
mucosal sites of initial pathogen entry. We sought to immunize
against fungal respiratory pathogens by delivering vaccines
into the respiratory tract. Although delivery of an attenuated
strain of Blastomyces dermatitidis (Bd) into the skin protects
100% of mice against a lethal pulmonary challenge, and most
develop sterilizing immunity (Wu¨thrich et al., 2000), vaccine
delivery intranasally (i.n.) failed to protect and 100%of vaccinees
succumbed to infection. Herein, we studied the mechanism
behind the failure in priming antifungal vaccine immunity at the
respiratory mucosa.
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Figure 1. Mucosal Vaccination Induces
Poor Th1 Cell Differentiation of Polyclonal
and Transgenic CD4+ Cells in Response to
Bd, but Robust Differentiation in Response
to Hc
Mice were vaccinated with attenuated Bd yeast or
Hc yeast i.t. *p < 0.05 versusmice infectedwithHc.
(A) After i.t. vaccination, cells were harvested from
lung 7 days later and stained by FACS to
enumerate the number and percentage of acti-
vated (CD44+) polyclonal CD4+ T cells. Lung CD4+
T cells were analyzed for intracellular IFN-g after
stimulation with anti-CD3 and -CD28 mAb for 4h.
Mean ± SEM of four mice per group.
(B) After mice received 106 naive 1807 cells i.v.,
they were vaccinated.Bd 1807 cell phenotype and
intracellular cytokine were assayed by gating on
Th1.1+ cells in FACS. Lung cells were harvested
7 days after i.t. vaccination. Dot plots show the
percentage of IFN-g+ Thy1.1+ CD4+ 1807 cells
after stimulation with anti-CD3 and -CD28 mAb for
4 hr. Cells from the MLN were harvested 7 days
after vaccination and stained so that the number
and percentage of activated (CD44+) Thy1.1+
CD4+ T cells could be assayed. T cells were
stimulated with CW/M antigen for 16 hr and
stained for IFN-g. Mean ± SEM of four mice per
group.
Immunity
Subversion of Antifungal ImmunityWe report that fungi subvert the induction of vaccine immunity
at the respiratory mucosa by inducing lung matrix metalloprotei-
nase 2 (MMP2), which suppresses the action of CCL7 and
impairs recruitment and maturation of Ly6Chi inflammatory
monocyte-derived DCs in the lung. Elimination of mature Ly6hi
DCs at this site retarded the activation, expansion, and differen-
tiation of IFN-g+ CD4+ T cells. Conversely, administering an
MMP2 inhibitor or CCL7 during vaccine delivery restored recruit-
ment of Ly6Chi monocytes to the lung and priming of CD4+
T cells. Our results pinpoint mechanisms that underpin vaccina-
tion against fungi at the respiratory mucosa. They also highlight
host andmicrobial strategies that must be overcome to engineer
fungal and other vaccines that induce respiratory mucosal
immunity. Mucosal vaccination against respiratory agents may
require manipulation of host MMPs that alter chemokine signals
needed to recruit Ly6Chi inflammatory monocytes and prime
CD4+ T cells at the respiratory mucosa.
RESULTS
Fungal Vaccination at the Respiratory Mucosa
Subcutaneous injection of mice with a live attenuated Bd strain
engenders 100% survival against a lethal pulmonary challenge
(Wu¨thrich et al., 2000), but inconsistent sterilizing immunity.
Because the natural route of infection is inhalation of spores,
we sought to enhance the vaccine’s efficacy by delivering it
into the respiratory tract. All mice vaccinated intranasal (i.n.)Immunity 36, 680–6(Wu¨thrich et al., 2000) or intratracheally
(i.t.) (data not shown) were unable to
control infection and died after pulmonary
challenge. This scenario contrasts with
that for Histoplasma capsulatum (Hc), inwhich primary pulmonary infection induces protective immunity
and resistance against lethal pulmonary challenge (Deepe and
Seder, 1998). Because these two fungal infections require
cellular immunity for resistance, we compared the priming of
CD4+ T cells for each of them to uncover the reasons for failure
versus success in priming of T cells at the respiratory mucosa.
Th1 cell differentiation occurs fully after CD4+ T cellsmigrate to
the lung (Rivera et al., 2006). Although i.t. vaccination with Bd
induced activated CD4+ T cells (CD44+) cells in the lung, Th1
cells failed to accrue and <1%produced IFN-g (Figure 1A). There
were z1,000-fold less IFN-g+ CD4 T cells in the lung after i.t.
vaccination with Bd compared with Hc. Hc induced a 1,000-
fold increase in the number of IFN-g+ CD4 T cells in the lung
upon mucosal vaccination, with nearly 14% producing IFN-g,
whereas Bd induced little increase. In contrast, s.c. administra-
tion of Bd, as well as Hc, lead to marked expansion of IFN-g+
cells during a recall response after challenge. Mice given Bd
s.c. had 100-fold more IFN-g+ cells than unvaccinated controls,
and more than 7% of CD4+ T cells produced this cytokine (Fig-
ure S1A available online).
Several mechanisms could explain the small number of
IFN-g+ cells and the inability of attenuated Bd to vaccinate at
the respiratory mucosa. First, the vaccine may not induce prolif-
eration of Bd specific CD4+ T cells or promote their survival.
Second it may not induce differentiation of Ag-specific T cells
in the drainingMLN. Third, Th1 CD4+ T cells may not be recruited
from MLN into the lung airways. Last, CD4 T cells may not fully92, April 20, 2012 ª2012 Elsevier Inc. 681
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Subversion of Antifungal Immunitydifferentiate or mature into Th1 cells in the lung. To distinguish
among these possibilities, and interrogate T cell priming, expan-
sion, differentiation and trafficking, we generated a TCR tg
mouse specific for Bd.
Generation and Characterization of a TCR tg Mouse
The Bd 1807 TCR tg mouse was engineered (Figures S1C–S1F;
see Supplemental Experimental Procedures) from a CD4+ T cell
clone that confers protective immunity against lethal pulmonary
challenge in mice (Wu¨thrich et al., 2007). Bd 1807 mice have an
increased prevalence of Va2+ CD4+ T cells in the peripheral
blood, spleen, and LNs versus wild-type B6 mice (Figure S1E).
Naive CD4+ T cells from Bd 1807 mice became activated
and proliferated in response to cell wall-membrane antigen
(CW/M), whereas CD4+ T cells from naive wild-type mice did
not respond to CW/M (Figure S1F). Thus, Bd 1807 cells are
specific and responsive to Bd in vitro.
Bd 1807 cells respond to Bd and cross-react withHc after s.c.
vaccination (Wu¨thrich et al., 2011b), they becomeactivated in the
draining LNs, differentiate into Th1 effector cells on migration to
the vaccine site, and exhibit memory and recall to lung upon
lethal pulmonary infection. Bd 1807 cells not only show fidelity
with polyclonal CD4+ T cells, but they also report the behavior
of CD4+ T cells that confer protective immunity (Wu¨thrich et al.,
2007). Thus, Bd 1807 cells enable interrogation of CD4+ T cell
priming, expansion and trafficking in response to both fungi,
and comparisons of these events between them.
Disparate Vaccine Priming ofBd 1807Cells byBd versus
Hc at the Respiratory Mucosa
We compared the priming ofBd 1807 tg CD4+ T cells in response
to vaccination with Bd or Hc in the lung. Although Bd 1807 cells
respond vigorously to both fungi after vaccination s.c. (above),
when vaccine is instead given i.t., the activation, expansion,
and differentiation into IFN-g effector cells is sharply reduced
in mice given Bd versus Hc (Figure 1B). The discrepancies
between the two groups were most exaggerated for IFN-g+
1807 cells in the lung. Hc-vaccinated mice had >100-fold
more 1807 Th1 effector cells compared to Bd. In lung-draining
or mediastinal LNs (MLN), Bd-vaccinated mice also had 10-
to 100-fold fewer activated cells. In contrast, after s.c.
vaccine, Bd 1807 cells were activated (CD44+) in the sdLNs
efficiently in response to both fungi, and similar numbers of
antigen-specific IFNg+ T1 effector cells were recalled to the
lung (Figure S1B).
Thus, Bd 1807 cells let us pinpoint defects in priming CD4+
T cells after delivery of Bd vaccine in the lung, which are linked
to (1) impaired activation and expansion in the lung-draining
MLN and (2) profound failure to differentiate fully into Th1 IFN-
g-producing effector cells upon migration back to lung after
mucosal vaccination. These deficits probably underpin failed
vaccination by Bd at the respiratory mucosa. The results
contrast sharply with the robust priming, expansion, and differ-
entiation of Bd 1807 cells in response to Hc delivered via the
respiratory route and to Bd vaccine delivered by the s.c. route.
These differences raise the question: why does Bd vaccine fail
to prime T cells at the respiratory mucosa and what mechanism
accounts for the sharp disparity in vaccine priming in the lung by
these two closely related fungi?682 Immunity 36, 680–692, April 20, 2012 ª2012 Elsevier Inc.Recruitment of Ly6Chi Inflammatory Monocytes upon
Mucosal Vaccination
We analyzed the myeloid APCs recruited to the lung after
delivery of vaccine yeast into the respiratory tract. We looked
at CD103+ DCs, CD11b+ DCs, including inflammatory mono-
cyte-derived Ly6Chi DCs, alveolar macrophages, and neutro-
phils. We saw sharp differences in the influx of APCs and uptake
of yeast for the two fungi. CD11b+ DCs were among the most
prominent APCs recruited to the lungs by both fungi (Figures
2A and S2C–S2F). The sharpest difference between the two
fungi was in the influx of Ly6Chi CD11bhi cells. Ly6Chi monocytes
accounted for z10% of the lung cells in response to Hc
versus <1% for Bd (Figure 2B). By staining yeast with PKH26,
we honed in on lung APC that harbored yeast (Figures 2C, 2D,
and S2D–S2F). CD103+ DCs contained few yeast (Figure 3C).
In contrast, for both fungi, most yeast resided with CD11b+
DCs (Figures 2C and S2D) and also in macrophages and neutro-
phils (Figures S2E and S2F). Strikingly, there were >10-fold more
Ly6Chi CD11bhi cells in the lung harboring Hc versus Bd (Figures
2C and 2D).
The same disparity between these fungi was seen in the drain-
ing MLN (Figures 2E–2H). Ly6Chi CD11bhi cells were nearly
absent in the MLN of Bd-vaccinated mice (0.045%), whereas
the proportion of these cells in the MLN of Hc-vaccinated
mice was 30-fold higher (1.4%) (Figures 2E and 2F). Most
of the DCs that harbored yeast in MLN were CD11b+ DCs,
although some CD103+ cells also harbored yeast for both
fungi (Figure 2G). Still, the biggest difference between the two
fungi was again in Ly6Chi CD11b+ cells; the proportion of
these cells harboring Hc (7.2%) was z12-fold higher than that
for Bd (0.59%) (Figure 2G). Consequently, in the MLN, there
were >1000-fold more Ly6Chi inflammatory monocytes with Hc
(R103 cells) than Bd (%10 cells) (Figure 2H). Thus, the numbers
of Ly6Chi monocytes that are recruited to the lung and migrate
into the draining MLN, and the numbers of these DCs harboring
yeast, are sharply reduced in mice that received Bd compared
to Hc.
Bd Blocks the Recruitment of Ly6Chi Inflammatory
Monocytes to the Lung
The blunted entry of Ly6Chi monocytes into the lungs of Bd-
vaccinated mice could be due to either a failure to induce the
recruitment of these cells or, alternatively, an active process of
blocking their recruitment. To distinguish between the two possi-
bilities, we performed amixing experiment in whichwe addedBd
vaccine yeast to the inoculum of Hc given i.t. The addition of Bd
curtailed the recruitment of Ly6Chi monocytes into the lung byHc
(Figure 3A). In the mixed infection, the distribution and numbers
of DCs showed a paucity of Ly6Chi CD11b+ DCs (0.26%) that
was similar to mice vaccinated with Bd (0.19%) and much lower
than mice that received Hc (13.7%) (Figure 3A); the numbers of
total Ly6Chi DCs in the lung followed similar trends with almost
identical patterns for Bd and mixed infections, each much lower
than for Hc vaccination (Figure 3B). To see whether mixed infec-
tion perturbed the numbers of APC harboring yeast, we stained
the yeast with PKH26. The total number of yeast-loaded APCs in
the lung was increased in the mixed infection (Figure S3B),
although the numbers of Ly6Chi (and Ly6Chi CD11c+) cells that
harbored yeast was greatly reduced in the mixed-infection and
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Figure 2. Inflammatory Monocytes Are Recruited to the Lung in Response to Hc but Not Bd
(A) Mice received 105 attenuated Bd yeast or 106 Hc yeast i.t. Lungs were harvested 4 days after infection, digested with collagenase D, and stained for flow
cytometry. Cells were initially gated on FCS/SSC and then underwent live cell gating, based on fixable live/dead staining. Left column shows the phenotype of
lung DCs (MHCII+ CD11c+ cells) that stain positive for CD103 andCD11b. Right column shows the inflammatorymonocytes in the lung characterized by Ly6C and
CD11b expression, indicated in the circled gate.
(B) Percentage of lung cells that are inflammatorymonocytes after exposure to the fungi. Gate for percentages are shown in Figure 2A. *p < 0.05 versus respective
sample for Bd group. Error bars represent the mean ± SD of four mice per group. Data are representative of five independent experiments.
(C) The phenotype of lung cells containing PKH26+ yeast were identified as in (A).
(D) Number of total (black bars) and yeast-loaded (PKH26+) inflammatory monocyte (red bars) in the lung. Gate for percentages are shown in Figure 2C. Numbers
were calculated based upon FACS percentages and cell counts. *p < .05 versus respective sample in Bd group. Error bars represent the mean ± SD of four mice
per group. Data are representative of five independent experiments.
(E–H) Characterization of cells in the drainingMLNs ofmice that received fungi as above;MLNs are harvested at the same time as the lungs. Data from theMLNs is
depicted as in (A)–(D), respectively. *p < .05 versus the respective sample for the Bd group.
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Figure 3. Bd Retards the Influx and Maturation of Inflammatory Monocytes in the Lung
(A) Inflammatory monocyte phenotype in the lungs of mice that received 105 Bd, 106 Hc, or a mixture of yeast i.t. Gates in the top row depict the percentage of
inflammatory monocytes among total lung cells; gates in the bottom row show the percentage of inflammatory monocytes among lung cells containing PKH26+
yeast.
(B) Numbers of total Ly6Chi monocytes (black bars) and total Ly6Chi CD11c+ cells (gray bars) 4 days after mice received yeast i.t.. *p < 0.05 forHc group versusBd
alone- or mixed-fungal group. The numbers of yeast-loaded (PKH26+) Ly6Chi monocytes (red bars) and PKH26+ Ly6Chi CD11c+ cells (pink bars) 4 days after mice
received yeast i.t.. *p < 0.05 for Hc group versus Bd alone- or mixed-fungal group.
(C) Phenotype of inflammatory monocytes in MLN (top row) and of cells containing PKH26+ yeast (bottom row).
(D) Numbers of total Ly6Chi monocytes (black bars) and total Ly6Chi CD11c+ cells (gray bars) in the draining MLNs 4 days after mice received fungi i.t. *p < 0.05 for
Hc group versus Bd alone- or mixed-fungal group. **p < 0.05 for Hc group versus Bd group. Number of yeast-loaded (PKH26+) Ly6Chi monocytes (red bars) and
PKH26+ Ly6Chi CD11c+ cells (pink bars) in theMLN 4 days after mice received fungi i.t.. *p < 0.05 forHc group versus Bd alone- or mixed-fungal group. **p < 0.05
for Hc group versus Bd group.
(E) CD11c expression of PKH26+ Ly6Chi (middle row) and PKH26+ Ly6C+ (right row) cells in the lung of mice that received i.t. inoculation ofBd,Hc, or the two yeast
mixed. Arrow denotes the CD11c expression of the population indicated. Histogram of CD11c expression on PKH26+ Ly6C+ cells (the gate was drawn to include
both Ly6Chi and Ly6C+ cells) from mice that received i.t. inoculation of Bd (white), Hc (black), or the two yeast mixed (gray).
(F) CCR2 expression on Ly6Chi and Ly6C+ cells in the draining MLNs of mice 4 days after they received i.t. inoculation Hc (top row). The bottom row shows CCR2
expression on Ly6C+ CD11c+ cells in mice that received i.t. inoculation of Hc.
(G) Absolute number of Ly6C+ CD11c+ CCR2+ cells in the draining MLNs of mice that received i.t. inocula of Bd, Hc, or both yeast mixed together. Numbers are
derived from percentages based on flow analysis. *p < 0.05 for comparisons indicated in brackets. Error bars in (B), (D), and (G) represent themean ± SD of four to
five mice pre group and the data are representative of three independent experiments.
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Subversion of Antifungal ImmunityBd-alone groups, as compared to the H. capasulatum group
(Figure 3B). The patterns in the MLN mirrored those in the lung
(Figures 3C and 3D). Thus, Bd interferes with either recruitment
or entry and migration of Ly6Chi monocytes in the lung and
MLN and can do so even in the case of a strong inducing stim-
ulus like respiratory exposure to Hc.
Ly6Chi monocytes that enter the lung in response to infection
mature upon transition to DCs, involving downregulation of Ly6C
and upregulation of CD11c and MHC class II (Osterholzer et al.,
2009). We explored this process in the three groups: either yeast
alone or mixed together. For Ly6Chi monocytes that entered the
lung in response to mucosal vaccination with Bd, both the Ly6C
expression and the CD11c expression were much lower than
that compared to the Hc group, and the mixed infection yielded
a pattern similar to that for Bd alone (Figure 3E). Thus, in the
setting of Bd vaccine, low Ly6C expression was not due to the
maturation to CD11c+ DCs; the yeast instead blunted the matu-
ration of CD11cDCs.
Ly6Chi inflammatory monocytes trafficking to organs may
require CCR2 expression (Serbina et al., 2008). Over 90% of
the Ly6Chi monocytes that migrate into the MLNs in response
to Hc display CCR2 (Figure 3F). Among the CD11c+ Ly6C+ cell
population in theMLN in this setting, 90% express CCR2. Impor-
tantly, Ly6Chi CD11c+ CCR2+ cells numbered z5-fold more
after the mucosal delivery ofHc, compared to Bd or mixed infec-
tion (Figure 3G).
Mucosal Vaccination with Bd Retards Chemokine
Action, Blocking Egress of Ly6Chi Inflammatory
Monocytes from the Bone Marrow and Recruitment
into the Lung
We investigated mechanisms behind the impaired influx of
Ly6Chi inflammatory monocytes upon respiratory vaccination
with Bd. CCR2+ inflammatory monocytes emanate from the
bone marrow in response to chemokine signals, so we first
analyzed whether the defect in cell recruitment is due to failed
egress of cells from the bone marrow or failed entry into the
lung. In wild-type mice, the percentage of Ly6Chi monocytes in
the marrow wasz2-fold higher in animals that got Bd or mixed
infection, compared toHc (Figure 4A). This increase could be due
to trapping of cells in the marrow or increased production. To
distinguish these possibilities, we studied Ccr2/mice in which
these cells cannot exit the marrow (Serbina and Pamer, 2006).
Production is increased in the Hc group relative to the other
groups (Figure S4A), suggesting that overproduction does not
explain the accumulation for Bd relative to Hc in wild-type
mice. We did not see a difference between groups in the number
of circulating monocytes during 2–5 days after vaccination
(data not shown). Thus, mucosal delivery of Bd leads to failure
of egress and trapping of Ly6Chi monocytes in the marrow rather
than defective monocyte extravasation into the lung.
The major signals that induce egress of CCR2+ monocytes
from the bone marrow are CCL2 and CCL7 (Jia et al., 2008;
Tsou et al., 2007). To see whether Bd affected these chemo-
kines, we analyzed levels in the lungs and serum of mice from
the three groups. The most striking difference was elevated
serum levels of CCL7 in those that received Bd i.t. (Figure 4B).
We tested the activity of these sera in promoting migration of
Ly6Chi monocytes in vitro. Sera from mice that got Hc promotedthe migration of Ly6Chi monocytes, whereas sera from the Bd
group did not (Figure 4C). Thus, the elevated levels of CCL7 in
Bd sera failed to induce chemotaxis.
Chemokines can be inactivated by serine proteases of
mammalian or microbial origin. To test whether inactive CCL7
might explain the defects in bone marrow egress of Bd-vacci-
nated mice, we vaccinated the mice together with recombinant
CCL7. Recombinant CCL7 given to Bd-vaccinated mice
enhanced the egress of Ly6Chi monocytes out of the marrow
and induced their recruitment into the lungs (Figure 4D). Thus,
the elevated endogenous levels of CCL7 in serumwere not func-
tional in vivo.
Inactive chemokines can desensitize their receptor (Ali et al.,
2005). We studied the migration of bone marrow monocytes
in vitro in response to both CCL7 and CCL2. Ly6Chi monocytes
from naive mice showed az3-fold increase in migration toward
these chemokines compared to medium alone, whereas cells
from Bd-vaccinated mice showed significantly less migration
toward the ligands (Figure S4B). We further analyzed receptor
desensitization by measuring Ca2+ flux. The flux of bone marrow
Ly6Chi monocytes in response to CCL7 as well as CCL2 is
curtailed in cells from Bd-vaccinated mice compared to naive
mice (Figure 4E; data not shown). Thus, Ly6Chi monocytes
from Bd-vaccinated mice showed reduced sensitivity to their
ligands, promoting their trapping in the marrow and poor recruit-
ment to the lung.
Mammalian Lung MMP2 Is Induced by Fungal
Vaccination at the Respiratory Mucosa
Chemokines can be inactivated by mammalian MMPs. The
gelatinase MMP2 acts on CCL7 converting it into an inactive or
antagonistic form (McQuibban et al., 2000; McQuibban et al.,
2002). We investigated lung MMP2 in response to vaccination
at the respiratorymucosa. The level of activeMMP2 inbronchoal-
veolar lavage (BAL) fluid was several-fold higher in mice vacci-
nated with Bd versus Hc (Figure 5A). To see whether the MMP2
levels affected chemokine-mediated egress of Ly6Chi mono-
cytes from the marrow to the lung, we inhibited MMPs during
vaccine administration. The broad MMP inhibitor, GM6001, and
the MMP2-selective inhibitor promoted egress of Ly6Chi mono-
cytes from the bone marrow (Figure S5A) and increased their
recruitment to the lung inmice vaccinated i.t. withBd (Figure 5B).
These inhibitors did not affect the growth of the fungus in the lung
(data not shown). Vaccination ofMmp2/mice also augmented
the release of Ly6Chi monocytes from the marrow (Figure S5B)
and influx of these cells into the lung compared to vaccinated
wild-type mice (Figure 5C). Thus, induction of lung MMP2 and
inactive CCL7 underpin the trapping of Ly6Chi monocytes in the
bone marrow and their failure to traffic to the lung in response
to fungal vaccine administration at the respiratory mucosa.
Ly6Chi CD11b+ CCR2+ Cells and Vaccine Priming of Bd
1807 Cells at the Respiratory Mucosa
We examined how impaired influx of Ly6C+ CD11b+ CD11c+
CCR2+ cells upon vaccination affects priming of protective
CD4+ T cells in the lung, including Bd 1807 cells. We used
Ccr2/ mice to establish the contribution of Ly6Chi monocytes
(Figure 6A). Expansion ofBd 1807 cells in theMLNwasmarkedly
impaired in wild-type mice that received Bd or mixed infectionImmunity 36, 680–692, April 20, 2012 ª2012 Elsevier Inc. 685
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Figure 4. B. dermatititids Blocks Recruit-
meent of Ly6Chi Inflammatory Monocytes
to the Lung by Impairing CCL7-Induced
Egress of CCR2+ Cells from the Bone
Marrow
(A) Percentage of Ly6Chi CD11b+ cells in the bone
marrow 3 days after wild-type mice received i.t.
inoculation of Bd (105 yeast), Hc (106), or both
mixed together. Dot plots (left side) are represen-
tative of five mice per group. Histogram (right)
shows the mean ± SD for each group. Data are
representative of three experiments. *p < 0.05
versus Hc group.
(B) CCL7 levels in the serum of mice vaccinated as
in (A). Results are the mean ± SD of 5 mice per
group. *p < 0.05 versus Hc group.
(C) Ly6Chi CD11b+ enriched cells from the bone
marrow of naive mice were placed in the upper
chamber of a 24-well transwell plate. The bottom
chamber contains pooled serum from each group
(n = 5 mice per group) at 1:2 dilution in RPMI or no
serum as a control. The number of cells that
migrated into the bottom chamber was counted
after 6 hr of incubation. Error bars represent
mean ± SD of three replicates per group; re-
sults are representative of three independent
experiments.
(D) Treatment with CCL7 promotes egress of
Ly6Chi monocytes from the bone marrow and
into the lungs of mice after vaccination with Bd.
Mice were vaccinated with yeast by the respi-
ratory route as in (A). Mice received CCL7 i.v.
(200 ng/dose) twice a day on days 1 and 2 before
analysis on day 3. Results represent the mean ±
SD of five mice per group (data are representative
of two independent experiments).
(E) Bone marrow cells from naive mice or Bd-
vaccinated mice harvested 4 days later were
loadedwith Indo-1 and stimulated with CCL2. Free
[Ca2+]i was measured in monocytes by flow cy-
tometry and gating on CD11b+ and Ly6Chi cells
(panels on left). Ionomycin was used as a positive
control for maximal Ca2+ influx. Data are repre-
sentative of four mice per group and three exper-
iments. Results are expressed as percentage of
the normalized response (right panel) and calcu-
lated as follows: ([mean of Indo-1 UV-B/UV-A ratio
after chemokine (green shading)] – [mean of Indo-1 UV-B/UV-A ratio before chemokine (pink shading)])/(mean of Indo-1 UV-B/UV-A ratio during the response to
ionomycin (blue shading)] – [mean of Indo-1 UV-B/UV-A ratio, before chemokine addition (pink shading)]). Mean and SEM values were calculated for each group
and illustrated by histogram. Data are representative of three experiments.
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Subversion of Antifungal Immunityi.t., compared to Hc (Figure 6B). In the Ccr2/ mice, 1807 cells
again failed to expand in response toBd. Slightly higher numbers
of 1807 cells expanded in response toHc inCcr2/ versus wild-
type mice, but the difference was insignificant. However, the
differentiation of IFNg producing Th1 1807 cells in response to
Hc was sharply impaired in Ccr2/ mice in the MLN (Figures
6C and 6D), and especially after these T cells exited the nodes
and migrated back into the lung (Figures 6F and 6G). In addition
to impairing the differentiation of 1807 into Th1 cells, the loss of
CCR2 changed the ratio of cytokine producing 1807 cells in favor
of T13 and T17 cells in response toHc (Figure 6G). Thus, the loss
of CCR2+ Ly6Chi CD11b+ DCs, due to Bd or CCR2 deletion,
curtails activation, proliferation and Th1 differentiation of 1807
cells in the MLN and lung.686 Immunity 36, 680–692, April 20, 2012 ª2012 Elsevier Inc.Transfer of Ly6Chi CD11b+ CD11c DCs Enables Bd
to Prime T Cells in the Lung
We tested whether resupply of Ly6Chi CD11b+ CD11c+ DCs into
the lungs restored priming of Bd 1807 cells. We first established
conditions that lead to optimal recruitment after i.t. delivery of
Hc. These cells peaked by day 4 in the lung and day 7 in the
MLNs (Figures S6A and S6B). We collected Ly6Chi monocytes
from mice 7 days after exposure to Hc. We enriched the cells
by negative selection (Figure S6C), after which Ly6Chi mono-
cytes constitutedz15%of the population (10- to 15-fold enrich-
ment) and Ly6C+ cells made up z85%. Approximately 1% to
2% of the Ly6Chi monocytes harbored PKH26+ yeast (data not
shown). We transferred the Ly6C-enriched cells i.t. into Ccr2/
or wild-type mice and also delivered Bd or Hc by this route
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Figure 5. MMP2 Retards Recruitment of Ly6chigh Inflammatory Monocytes to the Lungs of Mice Vaccinated at the Respiratory Mucosa with
Attenuated Bd
(A) Lung MMP2 levels. Mice were inoculated i.t. with 105 Bd or 106Hc and lungMMP2 levels were assessed by zymography. The zymogram (upper panel) shows
pro- and active MMP2 in BAL samples pooled for 5 mice/group 3 days after vaccination. The histogram shows densitometry quantification of active MMP2.
Results are the mean ± SE of pixel intensity for mice (n = 5) in each group. *p < 0.05 versus Hc. Results are representative of 3 independent experiments.
(B) Inhibition of MMP2 promotes egress of Ly6chi monocytes from the marrow and recruitment to the lung. Mice were inoculated i.t. withHc or Bd as above either
with or without DMSO, GM6001 or MMP-2 inhibitor. On day 3, the percentage of Ly6Chi monocytes in the lung (lower panels) and the number (upper panel) was
determined by flow cytometry. Data are themean ± SD of 7-10mice/group from two independent experiments. *p < 0.05 forBd groups that received DMSO alone
versus GM6001 or MMP-2 inhibitors.
(C)Mmp2/mice show increased recruitment of Ly6chi monocytes into the lungs.Mmp2/ andwild-typemicewere vaccinatedwithBd (i.t.) or not as above and
four days later the percentage of Ly6chi monocytes in the lung (left panels) and the number (right panel) was determined by FACS. Data is representative of 4-5
mice/group and three independent experiments. *p < 0.05 versus all other groups.
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Figure 6. TheAbsence of InflammatoryMonocytesCurtails Activation CD4 TCells in the Lung-Draining LNs and Their Th1Cell Differentiation
There and in the Lung
(A) Recruitment of Ly6Chi monocytes (circled) into draining MLN of wild-type mice or Ccr2/ mice 4 days after i.t. vaccination.
(B) Expansion of Bd 1807 tg cells in the MLNs of wild-type orCcr2/mice that received Bd (105),H.capsulatum (106) or both. One day before infection, 106 1807
Thy1.1+ cells were transferred into Thy1.2+ mice. MLNwere harvested 9 days post-infection. Numbers were calculated based upon FACS percentage of Thy1.1+
cells in MLN. Error bars are the mean ± SD of 4-5 mice/group. *p < 0.05 for comparisons indicated by brackets. Data is representative of 2 independent
experiments. WT, wild-type.
(C and D) Number of IFN-g (black bar), IL-13- (gray bar), IL-17- (white bar) producing 1807 cells in the MLNs of WT and Ccr2/ mice. Cells from MLN were
cocultured overnight with irradiated splenocytes and Bd CW/M antigen, then stimulated for 4 hr with Golgistop at 37C and stained for intracellular cytokines.
Absolute numbers were calculated based upon FACS percentages shown in (D). Error bars indicate mean SD ± of four to five mice per group. *p < 0.05 for
comparisons indicated by brackets. Data are representative of two independent experiments.
(E) Total number of 1807 T cells recruited back to the lung 9 days after i.t. inoculation of yeast. 1807 tg cells in the lungwere analyzed as described in (B). Error bars
are the mean ± SD of four to five mice per group. *p < 0.05 for comparisons indicated by brackets. Data are representative of two independent experiments.
(F and G) Cytokine producing 1807 T cells recruited to the lung. For intracellular cytokine staining, single-cell suspension from the lung is incubated with
Golgistop, anti-CD3, and anti-CD28 for 4 hr at 37C on the day of harvest and then stained for IFN-g (black bar), IL-13 (gray bar), and IL-17 (white bar). Layout and
data analysis are as described in (C) and (D).
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Figure 7. Adoptive Transfer of Inflammatory Monocytes into the Lung Restores the Activation and Differentiation of IFN-g-Producing CD4+
T Cells in Response to Bd
(A and D) FACS data showingBd 1807 cells in the lung ofCcr2/ (A) andwild-type (D)mice 10 days after injection of yeast. Transferred 1807 cells were tracked by
the Thy1.1 marker (top row), and then IFN-g production by Thy1.1 cells was intercellularly analyzed (middle row). Polyclonal CD4+ T cells also were analyzed for
IFN-g production by ICS (bottom row). ‘‘+DCs’’ indicates that the group received inflammatory DCs as indicated in (A). Groups labeled Bd or Hc received i.t.
inocula of the respective yeast.
(B and C) Total number of IFN-g-producing 1807 cells (B) or polyclonal CD4+ T cells (C) in Ccr2/ mice. Numbers were calculated on the basis of FACS
percentages shown in (A). Error bars represent the mean ± SD of four mice per group. *p < 0.05 for comparisons indicated by brackets.
(E and F) Total number of IFN-g-producing 1807 T cells (E) and polyclonal CD4+ T cells (F) inWTmice. Numbers were calculated on the basis of FACSpercentages
shown in (D). Error bars represent the mean ± SD of four mice per group. *p < 0.05 for comparisons indicated by brackets.
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Subversion of Antifungal Immunity(Figure S6C). We verified that congenic transferred DCs per-
sisted in the lungs over several days (Figure S6D). We analyzed
the priming and differentiation of separately transferred Bd 1807
cells (and endogenous CD4+ T cells) in lungs 9 days after DC
transfer.
In Ccr2/ mice, transfer of Ly6Chi monocytes enhanced the
number of IFN-g+ 1807 cells after mucosal vaccination (Figures
7A–7C): they rosez100-fold in mice that received Bd (note Bd
only versus Bd + DCs in Figure 7B) and z10-fold in mice that
received Hc (note Hc only versus Hc + DCs). Similar trends
were observed among the polyclonal CD4+ T cells. Thus, the
Ly6Chi monocytes transferred intoCcr2/ recipients were func-
tional and re-established activation, differentiation, and recruit-
ment into the lungs of Th1 1807 cells.
Upon transfer into wild-type mice (Figures 7D–7F), Ly6Chi
monocytes exerted a similar augmentation of 1807 cell function
in the lungs. Transfer of Ly6Chi monocytes into unvaccinated
mice enhanced the number of IFN-g+ 1807 cells, whencompared to naive mice. Transfer of these cells into mice that
had been vaccinated i.t. with Bd had a more pronounced effect,
increasing the number of IFN-g-producing 1807 cells in the lung
by nearly 100-fold (Figure 7E; note Bd only versus Bd + DCs),
and the percentage of these cells by nearly 10-fold (Figure 7D;
note Bd only versus Bd + DCs). Comparable trends were
observed in the endogenous CD4+ T cell pool (Figures 7D and
7F). Thus, impaired recruitment and maturation of Ly6Chi mono-
cytes led to failed priming of CD4 T cells and skewing of their
differentiation away from Th1 cells upon mucosal vaccination
with Bd. These events were remediated by the adoptive transfer
of Ly6Chi monocytes.
DISCUSSION
CD4+ T cells that produce IFN-g are pivotal in immunity to fungi
(Cutler et al., 2007). Here, we found that respiratory mucosal
vaccination with Bd did not prime IFN-g-producing endogenousImmunity 36, 680–692, April 20, 2012 ª2012 Elsevier Inc. 689
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Subversion of Antifungal ImmunityCD4+ T cells. We used a TCR tg mouse to track Ag-specific
T cells to decipher the mechanism. The host response to atten-
uated fungus, involving exuberant MMP and restrained inflam-
mation, paradoxically undermined downstream priming of
T cells. This finding offers a cautionary note to vaccinologists
harnessing vaccine immunity at the respiratory mucosa.
Subcutaneous delivery of attenuated Bd recruits Ly6Chi DCs
to the injection site, which ferry yeast into the sdLNs (Ersland
et al., 2010). Respiratory mucosal delivery of the vaccine yeast
instead failed to recruit the cells. There were low numbers of
these cells in the lung and MLN and few harbored yeast. Bd
blocked recruitment and maturation of Ly6Chi DCs in the lung,
rather than simply failing to induce their influx and maturation.
The impact of Bd on Ly6Chi monocytes was selective. Uptake
of these yeast into APCs and their trafficking into MLNs was
not generally impaired, given that the number of APCs harboring
Bd in lung and MLN was comparable to that in mice exposed to
Hc alone or in a mixed infection. Thus, Bd led to a redistribution
of yeast from Ly6Chi monocytes, into other lung APCs.
Ly6Chi monocytes regulate the early host response to
Aspergillus lung infection by taking up conidia and trafficking
them into the draining MLN to prime CD4+ T cells (Hohl et al.,
2009). Ly6Chi monocytes are dispensable in priming CD4+
T cells in the spleen of mice that are systemically infected i.v.
with Aspergillus. Although Ly6Chi monocytes carry Bd yeast
into the sdLNs after s.c. vaccination (Ersland et al., 2010), in
Ccr2/mice lacking Ly6Chi DCs, other migratory skin and resi-
dent DCs compensate by delivering yeast into the draining no-
des to prime T cells. In contrast, during mucosal vaccine delivery
here, the modulation of Ly6Chi monocyte influx—either due to
Bd alone or in mixed infection, or in Ccr2/ mice—sharply
reduced the numbers of vaccine yeast delivered to the MLN
and impaired priming of T cells. Thus, Ly6Chi monocytes are
indispensible in fungal vaccine delivery and antigen priming
in the lung. Cryptococcus neoformans also induces the recruit-
ment into lung of Ly6Chi monocytes (Osterholzer et al., 2009),
which mature into CD11b+ CD11c+ DCs, downregulate Ly6C,
and promote resistance. In primary pulmonary histoplasmosis,
Ccr2/ mice have altered leukocyte influx in their lungs
and succumb to infection due to overproduction of IL-4 and
alternative activation of pulmonary macrophages (Szymczak
and Deepe, 2009).
Several chemokines can bind CCR2. CCL2 and CCL7 are the
main CCR2 ligands in inflammatory settings (Jia et al., 2008;
Tsou et al., 2007) and help mobilize monocytes from the bone
marrow. Vaccination with Bd led to trapping of these cells in
the marrow and was also associated with high levels of CCL7
in serum. The serum CCL7 in these mice was inactive, failing
to promote CCR2-dependent migration of Ly6chi monocytes in
chemotactic assays. Further, treatment of these vaccinated
mice with rCCL7 repaired the deficit, promoting egress of
CCR2+ cells from the marrow and entry into the lung. We
propose that CCL7 was rendered inactive by MMP2 because
this product was elevated in Bd-vaccinated mice and its inhibi-
tion relieved marrow trapping and promoted Ly6Chi cell recruit-
ment to the lung. Removal of N-terminus residues of CCL7 by
MMP2 impairs its activity, yet CCL7 can still bind its receptor
and compete with CCL2 (McQuibban et al., 2000; McQuibban
et al., 2002). Host MMP2 may have modified CCL7 impairing690 Immunity 36, 680–692, April 20, 2012 ª2012 Elsevier Inc.its action, perhaps also antagonizing CCL2. Inflammatory mono-
cytes from the marrow of Bd-vaccinated mice showed reduced
sensitivity and response to CCL2. Although these defects could
be partially corrected with exogenous rCCL7, we did not
measure serum CCL7 levels after treatment and cannot exclude
a pharmacological effect. In hepatitis C, serum CXCL10, which
recruits lymphocytes to the liver by binding surface CXCR3, is
paradoxically elevated in the patients who fail therapy (Casrouge
et al., 2011). Elevated levels of the protease dipeptidyl peptidase
IV (DPP4) cleaves CXCL10, converting it from an agonist into an
antagonist of CXCR3. Although MMP2 probably acts similarly
herein, we cannot exclude a role for other MMPs including being
of fungal origin.
Impaired recruitment and maturation of Ly6Chi monocytes by
Bd blunted the activation, expansion, and differentiation of IFN-
g-producing T cells in the draining MLN and profoundly altered
differentiation of T cells on migration to the lungs. Bd 1807 cells
showed deficits in these functions after respiratory mucosal
vaccination with Bd (but not after s.c. vaccination). Because
Bd 1807 cells recognize a shared antigen inBd andHc, we could
show that priming and Th1 differentiation of these T cells byHc is
impaired not only in Ccr2/ mice, but also in wild-type mice
upon mucosal delivery of mixed Bd and Hc. Thus, yeast modu-
lation of Ly6Chi monocytes mediates failed T cell priming after
mucosal vaccination with Bd. We substantiated the role of Ly6-
Chi monocytes by adoptive transfer, which restored priming,
expansion, and Th1 cell differentiation of Bd 1807 cells. Consis-
tent with our findings, prior reports showed that inflammatory
monocyte-derived DCs stimulate Th1 immune responses. In
Ccr2/ mice, Th1 CD4+ T cell responses are impaired due to
reduced monocyte recruitment to inflamed LNs and diminished
production of IL-12 at the time of CD4+ T cell priming (Nakano
et al., 2009; Peters et al., 2000; Peters et al., 2001). Similarly, in
pulmonary cryptococcosis, Ccr2/ mice redirect CD4+ T cell
differentiation from Th1 to Th2 cells (Blease et al., 2000; Traynor
et al., 2000).
Impaired recruitment and maturation of Ly6Chi monocytes
skewed the differentiation of Bd 1807 cells toward IL-13- and
IL-17-producing cells. This was especially evident in the 1807
cells that had fully differentiated after migrating back to the lung
inCcr2/mice that receivedHc. Thiswas also true for 1807 cells
in mice that received mixed infection. Our findings suggest that
other APCs in the lung of wild-type mice that received Bd or
mixed infection or in theCcr2/mice that receivedHc, promote
the differentiation of CD4+ T cells into IL-13- and IL-17-producing
cells. Szymczak and Deepe (2009) found that lung IFN-g levels
were unaltered in Hc infected Ccr2/ mice, but elevated IL-4
levels instead led to their death. IL-17 levels were not reported
in that study, but it was not possible to track Ag-specific T cells
to assess skewed differentiation in the LNs or lung.
Priming Ag-specific immunity at mucosal sites of pathogen
entry is an active area in vaccine development. Our study high-
lights pitfalls in applying this strategy broadly across pathogen
kingdoms. There are four commercially available mucosal
vaccines: polio, rotavirus, Salmonella typhi, and influenza—
each a live, attenuated vaccine. HIV vaccine development is
focused on strategies for a mucosal vaccine. Intranasal vaccine
delivery of respiratory viruses is thought to prime immunity in
nasal mucosa-associated lymphoreticular tissue, and engage
Immunity
Subversion of Antifungal Immunitynot only s-IGA, but also T cell immunity, particularly CTLs.
Persistent antigen in the lung after influenza A infection fosters
antigen uptake by specialized respiratory DC that primememory
T cells (Kim et al., 2010). Although CCR2+ cells govern resistance
toM. tuberculosis (Peters et al., 2001), enhanced recruitment of
inflammatory monocytes to the lungs of mice infected with
M. tuberculosis with intranasal poly-IC unexpectedly enhanced
pathogen growth in this permissive population and lung tissue
injury despite unaltered production of IFN-g (Antonelli et al.,
2010).
These studies illustrate differences among pathogen king-
doms in vaccine or therapeutic strategies targeted to respiratory
sites of pathogen entry. Our work sheds new light on this vari-
ability by highlighting the role of chemokines and their cellular
targets in inducing mucosal immunity and by unveiling the para-
doxical effect of the host in undermining immunity to a mucosal
vaccine. To optimize the efficacy of mucosal vaccination, suit-
able vaccine adjuvants may thus need to target host MMP
responses that counter adaptive immunity at the lung mucosa.
Targeted recruitment of leukocytes to the lung on vaccination
may augment vaccine strategies.
EXPERIMENTAL PROCEDURES
Fungi
Bd strain 55, Hc strain G217B and C. albicans strain SC5314 were previously
described (Brandhorst et al., 1999). For a detailed description, see Supple-
mental Experimental Procedures.
Mice
The generation and characterization of Bd 1807 mice is described in detail in
the accompanying Supplemental Experimental Procedures.
Desensitization Studies
For measuring monocyte migration in response to serum or chemokine,
bone marrow cells were enriched for Ly6ChiCD11b+ cells, placed in the
upper chamber of transwell plates, and allowed to migrate through the
trans-membrane. For Ca2+-flux measurement, monocytes were loaded with
Indo-1 and stimulated with chemokine, and the flux was recorded over time
by flow cytometry. For a detailed description, see Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures (including adoptive transfer of Bd 1807 cells, vaccination and
experimental infection, PKH26 staining of yeast, lung andmediastinal LN prep-
aration, flow cytometry, adoptive transfer of inflammatory monocytes, gener-
ation of bone marrow dendritic cells, zymography, chemokine analysis and
administration of recombinant CCL7 into mice, chemotaxis assay, calcium
flux measurements, in vivo treatment with MMP2 inhibitors, and statistics)
and can be found with this article online at doi:10.1016/j.immuni.2012.02.015.
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